Team
Physiomics team members are passionate specialists with a wealth of knowledge and experience in cancer biology, quantitative pharmacology and mathematical modelling.
Dr Jim Millen
Non-Executive Chairman
Dr Jim Millen brings over 15 years experience in pharmaceuticals and biotechnology.
Learn more
Dr Peter Sargent
Chief Executive Officer
Dr Peter Sargent brings over 18 years of experience working within the life sciences sector.
Learn more
Dr Christophe Chassagnole
Chief Scientific Officer
Dr Christophe Chassagnole has led systems biology and bio-computing projects for over 15 years.
Learn more
Anthony Clayden
Head of Finance
Anthony Clayden brings over 22 years experience guiding high growth potential businesses.
Learn more
Hayley Close
Head of Business Development
Hayley Close joins Physiomics with 5 years business development experience.
Learn more
Dr Frances Brightman
Project Leader
Dr Frances Brightman is a computational biology specialist with over 21 years experience.
Learn more
Dr Nathalie Dupuy
Senior Biosimulation Scientist
Nathalie Dupuy is a biomedical computational scientist with experience in data science, machine learning and computational neuroscience.
Learn more
Dr David Hodson
Biosimulation Scientist
David Hodson is a mathematical biologist with experience in pharmacometrics and PKPD modelling.
Learn more
Dr Léa Sta
Biosimulation Scientist
Léa Sta is an applied mathematician with experience in cell signalling and receptor-ligand models.
Learn more
Charmaine Fraser
Office Manager
Charmaine Fraser brings with her over 10 years of Administrative and Managerial experience.
Learn more
Dr Hitesh Mistry
Principal Consultant, Clinical Modelling
Dr Hitesh Mistry, is a modelling and simulation specialist within the pharmaceutical industry.
Learn more
Dr Claire Villette
Consultant, Modelling and Simulation
Dr Claire Villette is a biomedical computational scientist with 9 years experience.
Learn more
Scientific Advisors
Dr Robert Jackson
Consultant and Scientific Advisory Board Member
Dr Robert Jackson obtained his PhD in biochemical pharmacology from the Institute of Cancer Research and has led many senior appointments in multinational pharmaceuticals.
Learn more
Professor Mark Middleton
Consultant and Scientific Advisory Board Member
Mark Middleton is Professor of Experimental Cancer Medicine at Dept. of Oncology and consultant Medical Oncologist at Oxford Cancer and Haematology Centre.
Learn more
Professor David Fell
Co-Founder and Scientific Advisory Board Member
David Fell is Professor of Biochemistry & Assistant Dean, School of Life Sciences at Oxford Brookes University, specialising in systems biology and metabolic modelling.
Learn more